Canon U.S.A. Enters into Collaborative Research Agreements with Massachusetts General Hospital and Brigham and Women’s

  Canon U.S.A. Enters into Collaborative Research Agreements with
  Massachusetts General Hospital and Brigham and Women’s Hospital

Business Wire

BOSTON -- November 13, 2012

Canon U.S.A., Inc., has entered into respective collaborative research
agreements with Massachusetts General Hospital (MGH) and Brigham and Women’s
Hospital (BWH) to develop biomedical optical imaging and medical robotics
technologies, among other initiatives. The overall goal of the agreements is
to develop and commercialize unique medical devices for a variety of
applications including detection of cardiovascular disease, brain functional
imaging, robotics-assisted neurosurgery and miniature endoscopy. Canon U.S.A.
is working in conjunction with its parent, Canon Inc., on this endeavor.

This collaboration involves technology experts from the MGH Wellman Center for
Photomedicine, MGH Athinoula A. Martinos Center for Biomedical Imaging, MGH
Pathology Imaging and Communication Technology (PICT) Center, BWH National
Center for Image Guided Therapy and BWH Center for Image-based Phenotyping.
Together with the support of research and development staff from Canon U.S.A.
and Canon Inc., they will work towards a common vision of pairing optics with
pioneering diagnosis.

“Canon is very excited to be collaborating with these world-class hospitals to
help solve clinical challenges facing healthcare communities worldwide,” said
Dr. Toshiaki Ikoma, executive vice president and chief technology officer,
Canon Inc. “Canon is committed to enhancing our worldwide R&D efforts while
emphasizing our medical imaging through the creation of the Healthcare Optics
Research Laboratory in Boston. The mission of the new laboratory is to
research, develop, and facilitate the commercialization of unique medical
devices. While we are in the very early stages of our research, we look
forward to a long affiliation with one another to help ensure the results of
our clinical findings are implemented in the future.”

"These agreements are quite different from the usual academic-industrial
agreements because we will be working together to bring new MGH- and
BWH-invented technologies from their current, very early stage, through
prototype and scale-up, to our ultimate goals of FDA approval and clinical
adoption," noted Dr. Frances Toneguzzo, executive director of the Office of
Research Ventures & Licensing that manages innovations developed at MGH and
BWH. "Together the parties will be dedicated to developing this technology
from its basic scientific principles all the way to initial prototyping within
the biological research and clinical environments with the ultimate goal of
bringing these products to the patient.”

Massachusetts General Hospital is the original and largest teaching hospital
of Harvard Medical School and conducts the largest hospital-based research
program in the United States, with an annual research budget of more than $600
million and major research centers in AIDS, cardiovascular research, cancer,
computational and integrative biology, cutaneous biology, human genetics,
medical imaging, neurodegenerative disorders, regenerative medicine, systems
biology, transplantation biology and photomedicine. For more information about
Massachusetts General Hospital, visit www.massgeneral.org.

Brigham and Women’s Hospital, a non-profit teaching affiliate of Harvard
Medical School, is dedicated to serving the needs of the local and global
community, providing the highest quality health care to patients and their
families, expanding the boundaries of medicine through research and educating
the next generation of health care professionals. For more information about
Brigham and Women’s Hospital, visit www.brighamandwomens.org.

Canon Inc. (NYSE: CAJ), headquartered in Tokyo, Japan, is a leader in the
fields of professional and consumer imaging equipment and information systems.
Canon’s extensive range of products includes copying machines, inkjet and
laser printers, cameras, video equipment, medical equipment and
semiconductor-manufacturing equipment. Originally established in 1937 as
Precision Optical Industry, Co., Ltd., a camera manufacturer, Canon has
successfully diversified and globalized to become a worldwide industry leader
in professional and consumer imaging systems and solutions.

With over 200,000 employees worldwide, Canon has manufacturing and marketing
subsidiaries in Japan, the Americas, Europe, Asia and Oceania; and a global
R&D network with companies based in the United States, Europe, Asia and
Australia.

Canon’s consolidated net sales for fiscal 2011 (ended December 31, 2011)
totaled $45.6 billion (at an exchange rate of ¥78=US$1) and ranks third
overall in U.S. patents registered in 2011†. Visit the Canon Inc. website at:
www.canon.com

Canon U.S.A., Inc., is a leading provider of consumer, business-to-business,
and industrial digital imaging solutions. In 2012, Canon U.S.A. has received
the PCMag.com Readers’ Choice Award for Service and Reliability in the digital
camera and printer categories for the ninth consecutive year, and for
camcorders for the past two years. Canon U.S.A. is committed to the highest
level of customer satisfaction and loyalty, providing 100 percent U.S.-based
consumer service and support for all of the products it distributes. Canon
U.S.A. is dedicated to its Kyosei philosophy of social and environmental
responsibility. To keep apprised of the latest news from Canon U.S.A., sign up
for the Company's RSS news feed by visiting www.usa.canon.com/rss.

†Based on weekly patent counts issued by United States Patent and Trademark
Office.

All referenced product names, and other marks, are trademarks of their
respective owners.

Contact:

Editorial Contact:
Canon U.S.A., Inc.
Siobhan Cullagh, 516-328-4602
scullagh@cusa.canon.com
or
Canon U.S.A. Website:
http://www.usa.canon.com
or
For sales info./customer support:
1-800-OK-CANON
 
Press spacebar to pause and continue. Press esc to stop.